4.5 Article

MMP-2,-3 and-9 levels and activity are not related to Aβ load in the frontal cortex in Alzheimer's disease

Related references

Note: Only part of the references are listed.
Article Geriatrics & Gerontology

Impact of the matrix metalloproteinase MMP-3 on dementia

Nicole Helbecque et al.

NEUROBIOLOGY OF AGING (2007)

Article Biochemistry & Molecular Biology

Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity

Anthony R. White et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Clinical Neurology

Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease

S Baig et al.

ACTA NEUROPATHOLOGICA (2005)

Article Biochemistry & Molecular Biology

Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain

J Dzwonek et al.

FEBS LETTERS (2004)

Article Neurosciences

The role of matrix metalloproteinase-9 in dementia

N Helbecque et al.

NEUROSCIENCE LETTERS (2003)

Article Biochemistry & Molecular Biology

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease

S Lorenzl et al.

NEUROCHEMISTRY INTERNATIONAL (2003)

Review Neurosciences

Metalloproteinases in biology and pathology of the nervous system

VW Yong et al.

NATURE REVIEWS NEUROSCIENCE (2001)

Article Clinical Neurology

Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain

Y Yoshiyama et al.

ACTA NEUROPATHOLOGICA (2000)